Tacrograf 1mg (tacrolimus)

Tacrograf is a pharmaceutical product manufactured by Sun Pharmaceutical Industries Ltd., a multinational pharmaceutical company based in India. Use of this medication is primarily indicated for patients who have undergone organ transplantation to prevent rejection by the immune system. Tacrolimus, the active ingredient, was originally discovered in Japan in 1987.

Today, Sun Pharma is the brand owner and primary manufacturer. The company operates a massive global network, and while formulation and packaging for specific markets like the UK or South Africa may happen in different regional hubs, the primary manufacturing origin of the Tacrograf brand remains rooted in Sun Pharma's extensive facilities in India. As one of the world's largest specialty generic pharmaceutical companies, Sun Pharma manages the entire lifecycle of the brand from its headquarters in Mumbai.